BAYRY gains FDA Priority Review for asundexian NDA after phase III data showed a 26% cut in ischemic stroke risk without more ...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) ...

US FDA & Japan’s MHLW accept Bayer’s FXIa inhibitor, asundexian for prevention of ischemic stroke: Berlin Wednesday, May 20, 2026, 12:00 Hrs [IST] Bayer announced that the US ...

Asundexian plus antiplatelet therapy reduces IS risk in patients with noncardioembolic stroke or high-risk transient ischemic attack.

In the phase 3 OCEANIC-STROKE trial, asundexian significantly reduced recurrent ischemic stroke risk compared with placebo without significantly increasing major bleeding. The Food and Drug ...

Transient ischaemic attack (TIA) represents a brief episode of neurological dysfunction caused by focal cortical or retinal ischaemia without acute infarction. Globally, the annual incidence of TIA ...

All the wonderful and most welcome signs of the new life surround us. (Sorry, allergy sufferers! I do feel your pain!)  The ...

China’s CDE grants Priority Review designation for Bayer’s marketing authorization application for asundexian: Berlin Friday, May 8, 2026, 10:00 Hrs [IST] Bayer, a global ente ...

A "mini stroke" or TIA is a warning sign that a full stroke may be imminent. Learn the symptoms and what to do, according to Fairfield Medical Center.

In a recent TikTok video, neurologist Dr Baibing Cheng (known online as Dr Bing) said: “I’ve seen strokes caused by things ...

Global stroke incidence and prevalence continue rising alongside high, underrecognized OSA prevalence and rapidly expanding diabetes burden, with substantial bidirectional comorbidity in type 2 ...

“I was completely shocked that going to a chiropractor had contributed to this,” said Jaycie Conley ...